Skip to main content

Table 4 Analysis of hospital outcomes by myosteatosis

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

  All patients (n = 77)
n (%)
No myosteatosis (n = 51)
n (%)
Myosteatosis (n = 26)
n (%)
p-value
Major complication (Clavien-Dindo ≥ 3a) 16 (21) 9 (18) 7 (27) 0.254a
Major intra-abdominal leak 11 (14) 5 (10) 6 (23) 0.111a
Length of hospital admission, days (median, IQR) 10 (8–15) 10 (7–13) 13 (9–24) 0.039b
Hospital readmission < 30 days 10 (13) 3 (6) 7 (27) 0.011c
  1. IQR interquartile range
  2. a χ2 test, b Mann-Whitney U test, c Fischer’s exact test